Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Integrated network pharmacology and cellular assay reveal the biological mechanisms of Limonium sinense (Girard) Kuntze against Breast cancer

Fig. 6

Molecular docking analysis of Apigenin with hub target proteins. A-F Graphs showing the binding mode and molecular interactions of Apigenin with AKT1, EGFR, SRC, ESR1, GSK3B and PTGS2, respectively. The 3D graphs showing the binding model of Apigenin and each target. The 2D graphs showing the specific interactions between Apigenin and the hub targets

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us